Global Skin Microbiome Modulators Market

1. Global Skin Microbiome Modulators Market Focus on Products, Applications, Distribution Channels, Country Data (14 Countries), and Competitive Landscape: Analysis and Forecast: 2019-2030 July 2020 TOC

2. Global Skin Microbiome Modulators Market BIS Research is a leading market intelligence and technology research company. BIS Research publishes in-depth market intelligence reports focusing on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. Copyright © 2020 BIS Research All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. All rights reserved at BIS Research 2

3. Global Skin Microbiome Modulators Market T Table of able of C Contents ontents Executive Summary……………………………………………...……………. 18 1.Product Definition .................................................................................................. 25 1.1 Inclusion and Exclusion ............................................................................... 25 2.Market Scope .......................................................................................................... 26 2.1 2.2 Scope of Work ............................................................................................... 26 Key Questions Answered in the Report ...................................................... 27 3.Research Methodology .......................................................................................... 28 3.1 3.2 3.3 3.4 3.5 Global Skin Microbiome Modulators Market: Research Methodology ..... 28 Primary Data Sources ................................................................................... 29 Secondary Data Sources .............................................................................. 30 Market Estimation Model .............................................................................. 30 Criteria for Company Profiling ..................................................................... 34 4.Market Overview ..................................................................................................... 35 4.1 4.2 4.3 4.4 4.5 Market Definition ........................................................................................... 35 The Human Microbiome Project: 2007-2016 ............................................... 37 Market Size and Growth Potential, $Million, 2019-2030 ............................. 40 Future Potential ............................................................................................. 41 COVID-19 Impact on the Global Skin Microbiome Modulators Market ..... 42 5.Industry Insights ..................................................................................................... 44 5.1 5.2 5.3 5.4 Overview ........................................................................................................ 44 Legal Requirements and Framework in the U.S. ........................................ 44 Legal Requirements and Framework in Europe ......................................... 44 Legal Requirements and Framework in Asia-Pacific ................................. 45 5.4.1 China ............................................................................................... 45 Funding Scenario .......................................................................................... 46 Patent Analysis ............................................................................................. 48 5.6.1 Overview ......................................................................................... 48 5.5 5.6 All rights reserved at BIS Research 3

4. Global Skin Microbiome Modulators Market 5.6.2 5.6.3 5.6.4 5.6.5 Global Microbiome Consortiums ................................................................. 51 Patent Classification ...................................................................... 48 Regional Analysis........................................................................... 49 Microorganism Analysis ................................................................ 50 Key Highlights ................................................................................ 50 5.7 6.Market Dynamics .................................................................................................... 54 6.1 6.2 6.3 Overview ........................................................................................................ 54 Impact Analysis ............................................................................................. 54 Market Drivers ............................................................................................... 55 6.3.1 Increasing Emphasis on Microbiome’s Potential for Human Health .............................................................................................. 55 6.3.2 Increasing Entry of Legacy Cosmetic Companies into Skin Microbiome Modulators Industry .................................................. 57 6.3.3 Decreasing Cost of Sequencing.................................................... 57 Market Restrains ........................................................................................... 58 6.4.1 Non-Standardization of Claims and Stringent Regulatory Standards ........................................................................................ 58 6.4.2 Lack of Knowledge on Probiotic-Based Products ....................... 59 6.4.3 Cost of the Cosmetic Products-Based on Probiotics ................. 60 Market Opportunities .................................................................................... 61 6.5.1 Investiture of Next-Generation Probiotics for Enhancement of Probiotic Drugs .............................................................................. 61 6.5.2 Growing Integrative Industry-Academia Collaboration ............... 61 6.5.3 Pipeline Drugs Anticipated Future Potential to the Skin Microbiome Modulators Market .................................................... 62 6.4 6.5 7.Competitive Landscape ......................................................................................... 64 7.1 7.2 7.3 7.4 7.5 7.6 Synergistic Activities .................................................................................... 65 Business Expansion Activities and Others ................................................ 66 Product Launches and Product Updates .................................................... 66 Mergers and Acquisitions ............................................................................ 67 Market Share Analysis, 2018-2019 ............................................................... 67 Growth Share Analysis ................................................................................. 69 All rights reserved at BIS Research 4

5. Global Skin Microbiome Modulators Market 7.6.1 7.6.2 7.6.3 Pipeline Analysis (2017-2019) ...................................................................... 76 Growth Share Analysis (by Company) ......................................... 69 Growth Share Analysis (by Application) ...................................... 72 Growth Share Analysis (by Country) ............................................ 74 7.7 8.Global Skin Microbiome Modulators Market (by Product Type) ......................... 78 8.1 8.2 8.3 8.4 Overview ........................................................................................................ 78 Probiotics ....................................................................................................... 79 Prebiotics ....................................................................................................... 84 Drugs .............................................................................................................. 86 9.Global Skin Microbiome Modulators Market, (by Application) ........................... 89 9.1 9.2 9.3 9.4 Overview ........................................................................................................ 89 Skin Care ........................................................................................................ 90 Hair Care ........................................................................................................ 93 Other Applications ........................................................................................ 94 10.Global Skin Modulators Market (by Distribution Channels) ............................... 96 10.1Overview ........................................................................................................ 96 10.2Online Channels ............................................................................................ 97 10.3Hypermarkets and Supermarkets ................................................................ 98 10.4Direct Selling ................................................................................................. 99 10.5Specialty Store ............................................................................................ 100 10.6Drug Stores .................................................................................................. 101 11.Global Skin Microbiome Modulators Market (by Region) ................................. 103 11.1Overview ...................................................................................................... 103 11.2North America ............................................................................................. 106 11.2.1 U.S. ................................................................................................ 108 11.2.2 Canada .......................................................................................... 110 11.3Europe .......................................................................................................... 112 11.3.1 Germany ........................................................................................ 115 11.3.2 France ............................................................................................ 116 11.3.3 U.K. ................................................................................................ 117 All rights reserved at BIS Research 5

6. Global Skin Microbiome Modulators Market Italy ................................................................................................ 118 Spain .............................................................................................. 119 Rest-of-Europe ............................................................................. 120 11.4Asia-Pacific .................................................................................................. 121 11.4.1 Japan ............................................................................................. 124 11.4.2 China ............................................................................................. 126 11.4.3 South Korea ...................................................................................... 127 11.4.3 Australia ........................................................................................ 128 11.4.4 India ............................................................................................... 129 11.4.5 Rest-of-APAC ................................................................................ 130 11.5Latin America .............................................................................................. 131 11.5.1 Brazil .............................................................................................. 134 11.5.2 Mexico ........................................................................................... 135 11.5.3 Rest-of-Latin America ...................................................................... 136 11.6Rest-of-the-World ........................................................................................ 137 11.3.4 11.3.5 11.3.6 12.Company Profiles ................................................................................................. 138 12.1Overview ...................................................................................................... 138 12.2AOBiome ...................................................................................................... 139 12.2.1 Company Overview ...................................................................... 139 12.2.2 Role of AOBiome in the Global Skin Microbiome Modulators Market ............................................................................................ 139 12.2.3 SWOT Analysis ............................................................................. 141 12.3Azitra, Inc. .................................................................................................... 142 12.3.1 Company Overview ...................................................................... 142 12.3.2 Role of Azitra, Inc. in the in the Global Skin Microbiome Modulators Market ....................................................................... 142 12.3.3 SWOT Analysis ............................................................................. 144 12.4Colgate-Palmolive Company ...................................................................... 145 12.4.1 Company Overview ...................................................................... 145 12.4.2 Role of Colgate-Palmolive in the Global Skin Microbiome Modulators Market ....................................................................... 145 12.4.3 Financials ...................................................................................... 147 All rights reserved at BIS Research 6

7. Global Skin Microbiome Modulators Market SWOT Analysis ............................................................................. 149 12.5Evelo Biosciences, Inc. .............................................................................. 150 12.5.1 Company Overview ...................................................................... 150 12.5.2 Role of Evelo Biosciences, Inc. in the Global Skin Microbiome Modulators Market .................................................. 150 12.5.3 SWOT Analysis ............................................................................. 152 12.6GALLINÉE .................................................................................................... 153 12.6.1 Company Overview ...................................................................... 153 12.6.2 Role of GALLINÉE in the Global Skin Microbiome Modulators Market ....................................................................... 153 12.6.3 SWOT Analysis ............................................................................. 155 12.7Glowbiotics, Inc. .......................................................................................... 156 12.7.1 Company Overview ...................................................................... 156 12.7.2 Role of Glowbiotics, Inc. in the Global Skin Microbiome Modulators Market ....................................................................... 156 12.7.3 SWOT Analysis ............................................................................. 158 12.8Johnson & Johnson Services, Inc. ............................................................ 159 12.8.1 Company Overview ...................................................................... 159 12.8.2 Role of Johnson & Johnson in the Global Skin Microbiome Modulators Market ....................................................................... 159 12.8.3 Financials ...................................................................................... 161 12.8.4 Key Insights about Financial Health of the Company ............... 162 12.8.5 SWOT Analysis ............................................................................. 163 12.9L’Oréal S.A. .................................................................................................. 164 12.9.1 Company Overview ...................................................................... 164 12.9.2 Role of L’Oréal S.A in the Global Skin Microbiome Modulators Market ....................................................................... 164 12.9.3 Financials ...................................................................................... 165 12.9.4 SWOT Analysis ............................................................................. 166 12.10MATRISYS BIOSCIENCE ............................................................................ 167 12.10.1Company Overview ...................................................................... 167 12.10.2Role of MATRISYS BIOSCINCE in the Global Skin Microbiome Modulators Market .................................................. 167 12.4.4 All rights reserved at BIS Research 7

8. Global Skin Microbiome Modulators Market 12.10.3SWOT Analysis ............................................................................. 169 12.11Quorum Innovations ................................................................................... 170 12.11.1Company Overview ...................................................................... 170 12.11.2Role of Quorum Innovations in the Global Skin Microbiome Modulators Market ....................................................................... 170 12.11.3SWOT Analysis ............................................................................. 172 12.12Revlon .......................................................................................................... 173 12.12.1Role of Revlon in the Global Skin Microbiome Modulators Market ............................................................................................ 173 12.12.2Financials ...................................................................................... 174 12.12.3Key Insights About Financial Health of the Company .............. 177 12.12.4SWOT Analysis ............................................................................. 178 12.13Siolta Therapeutics ..................................................................................... 179 12.13.1Company Overview ...................................................................... 179 12.13.2Role of Siolta Therapeutics in the Global Skin Microbiome Modulators Market ....................................................................... 179 12.13.3SWOT Analysis ............................................................................. 181 12.14The Estée Lauder Companies Inc. ............................................................. 182 12.14.1Company Overview ...................................................................... 182 12.14.2Role of The Estee Lauder Companies, Inc. in the Global Skin Microbiome Modulators Market .......................................... 182 12.14.3SWOT Analysis ............................................................................. 184 12.15TULA Life, INC ............................................................................................. 185 12.15.1Company Overview ...................................................................... 185 12.15.2Role of TULA Life, INC in the Global Skin Microbiome Modulators Market ....................................................................... 185 12.15.3SWOT Analysis ............................................................................. 187 12.16Unilever ........................................................................................................ 188 12.16.1Company Overview ...................................................................... 188 12.16.2Role of Unilever in the Global Skin Microbiome Modulators Market ............................................................................................ 188 12.16.3Financials ...................................................................................... 190 12.16.4SWOT Analysis ............................................................................. 192 All rights reserved at BIS Research 8

9. Global Skin Microbiome Modulators Market 12.17Yakult Honsha Co., Ltd ............................................................................... 193 12.17.1Company Overview ...................................................................... 193 12.17.2Role of Yakult Honsha Co., Ltd. in the Global Skin Microbiome Modulators Market .................................................. 193 12.17.3Financials ...................................................................................... 195 12.17.4SWOT Analysis ............................................................................. 197 All rights reserved at BIS Research 9

10. Global Skin Microbiome Modulators Market List o List of Tables f Tables Table 5.1: Global Microbiome Consortiums and Their Participants ................................................... 52 Table 6.1: Pipeline Drugs in the Skin Microbiome Modulators Market ............................................... 63 Table 8.1: Examples of Probiotics in the Global Skin Microbiome Modulators Market ..................... 81 Table 8.2: Examples of Prebiotics in Global Skin Microbiome Modulators Market ............................ 86 All rights reserved at BIS Research 10

11. Global Skin Microbiome Modulators Market List of List of Figures Figures Figure 1: Impact Analysis of Market Drivers and Market Challenges on the Global Skin Microbiome Modulators Market ...................................................................................... 19 Figure 2: Global Skin Microbiome Modulators Market (by Product), 2019 vs. 2030 ($Million) ......... 20 Figure 3: Global Skin Microbiome Modulators Market (by Application), 2019 vs. 2030 ($Million) .... 21 Figure 4: Global Skin Microbiome Modulators Market (by Distribution Channel), 2019 vs. 2030 ($Million) .......................................................................................................................... 22 Figure 5: Global Skin Microbiome Modulators Market Snapshot ....................................................... 23 Figure 2.1: Global Skin Microbiome Modulators Market Segmentation ............................................. 26 Figure 3.1: Global Skin Microbiome Modulators Market Research Methodology .............................. 28 Figure 3.2: Primary Research Methodology ........................................................................................ 29 Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis) .............................................................. 31 Figure 3.4: Top-Down Approach (Segment-Wise Analysis) ............................................................... 32 Figure 4.1: Human Microbiota Sites .................................................................................................... 36 Figure 4.2: Significant Milestones from the Human Microbiome Project (Phase 1)........................... 39 Figure 4.3: Global Skin Microbiome Modulators Market, 2019-2030 ................................................. 40 Figure 4.4: Global Skin Microbiome Modulators Market: COVID-19 Impact...................................... 42 Figure 5.1: Funding in Microbiome Projects (FY2012-FY2016) ......................................................... 46 Figure 5.2: Specific Microbial Members/Microbial Products Investigated in Microbiome Projects.... 47 Figure 6.1: Impact Analysis .................................................................................................................. 55 Figure 6.2: Annual NIH Funding in the Human Microbiome Research, FY2007-FY2016 ................. 56 Figure 6.3: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025) .... 58 Figure 7.1: Share of Key Developments and Strategies, January 2017-June 2020.......................... 64 Figure 7.2: Synergistic Activities Share (by Company), January 2017-February 2020 ..................... 65 Figure 7.3: Business Expansion Activities Share (by Company), January 2017- June 2020 ........... 66 Figure 7.4: Number of Product Launches (by Company), January 2017-June 2020 ........................ 67 Figure 7.5: Market Share Analysis for Global Skin Microbiome Modulators Market, 2018 and 2019 ................................................................................................................ 68 All rights reserved at BIS Research 11

12. Global Skin Microbiome Modulators Market Figure 7.6: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Company), 2019 ............................................................................................................. 70 Figure 7.7: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Application), 2019-2030 .................................................................................................. 72 Figure 7.8: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Country), 2019-2030 ....................................................................................................................... 74 Figure 8.1: Global Skin Microbiome Modulators Market (by Product Type) ...................................... 78 Figure 8.2: Global Skin Microbiome Modulators Market (by Product Type), 2019 and 2030 ........... 79 Figure 8.3: Global Skin Microbiome Modulators Market (by Probiotics), 2019-2030 ........................ 80 Figure 8.4: Global Skin Microbiome Modulators Market (by Probiotic Microbes), 2019 and 2030 .. 82 Figure 8.5: Global Skin Microbiome Modulators Market (by Bacterial Probiotics), 2019 and 2030 ................................................................................................................ 83 Figure 8.6: Global Skin Microbiome Modulators Market (by Prebiotics), 2019-2030 ........................ 85 Figure 8.7: Global Skin Microbiome Modulators Market (by Drugs), 2019-2030 ............................... 87 Figure 9.1: Global Skin Microbiome Modulators Market (by Application) .......................................... 89 Figure 9.2: Global Skin Microbiome Modulators Market (by Application), 2019-2030 ....................... 90 Figure 9.3: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030 ........................ 91 Figure 9.4: Global Skin Microbiome Modulators Market (by Skin Care Applications), 2019 and 2030 ................................................................................................................ 92 Figure 9.5: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030 ........................ 93 Figure 9.6: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030 ........................ 94 Figure 10.1: Global Skin Microbiome Modulators Market (by Distribution Channels) ....................... 96 Figure 10.2: Global Skin Microbiome Modulators Market (by Online Channels), 2019-2030 .......... 97 Figure 10.3: Global Skin Microbiome Modulators Market (by Hypermarkets and Supermarkets), 2019-2030 ....................................................................................................................... 98 Figure 10.4: Global Skin Microbiome Modulators Market (by Direct Selling), 2019-2030 ................. 99 Figure 10.5: Global Skin Microbiome Modulators Market (by Specialty Store), 2019-2030 ........... 100 Figure 10.6: Global Skin Microbiome Modulators Market (by Drug Stores), 2019-2030 ................. 102 Figure 11.1: Global Skin Microbiome Modulators Market (by Region), 2019 and 2030 .................. 103 All rights reserved at BIS Research 12

13. Global Skin Microbiome Modulators Market Figure 11.2: Global Skin Microbiome Modulators Market (by Region), 2019-2030 ......................... 104 Figure 11.3: Global Skin Microbiome Modulators Market Share (by Region), 2019 ....................... 105 Figure 11.4: Global Skin Microbiome Modulators Market Share (by Region), 2030 ....................... 105 Figure 11.5: North America Skin Microbiome Modulators Market, 2019-2030 ................................ 106 Figure 11.6: North America: Market Dynamics ................................................................................. 107 Figure 11.7: North America Skin Microbiome Modulators Market (by Country), 2019-2030 .......... 108 Figure 11.8: U.S. Skin Microbiome Modulators Market, 2019-2030................................................. 110 Figure 11.9: Canada Skin Microbiome Modulators Market, 2019-2030 ........................................... 111 Figure 11.10: Europe Skin Microbiome Modulators Market, 2019-2030 .......................................... 112 Figure 11.11: Europe: Market Dynamics ........................................................................................... 113 Figure 11.12: Europe Skin Microbiome Modulators Market (by Country), 2019-2030 .................... 114 Figure 11.13: Germany Skin Microbiome Modulators Market, 2019-2030 ...................................... 115 Figure 11.14: France Skin Microbiome Modulators Market, 2019-2030 .......................................... 116 Figure 11.15: U.K. Skin Microbiome Modulator Market, 2019-2030 ................................................ 117 Figure 11.16: Italy Skin Microbiome Modulators Market, 2019-2030 ............................................... 119 Figure 11.17: Spain Skin Microbiome Modulators Market, 2019-2030 ............................................ 119 Figure 11.18: Rest-of-Europe Skin Microbiome Modulators Market, 2019-2030 ............................ 120 Figure 11.19: Asia-Pacific Skin Microbiome Modulators Market, 2019-2030 .................................. 122 Figure 11.20: APAC: Market Dynamics ............................................................................................. 123 Figure 11.21: APAC Sin Microbiome Modulators Market (by Country), 2019-2030 ........................ 124 Figure 11.22: Japan Skin Microbiome Modulators Market, 2019-2030............................................ 125 Figure 11.23: China Skin Microbiome Modulators Market, 2019-2030 ............................................ 126 Figure 11.24: South Korea Skin Microbiome Modulators Market, 2019-2030 ................................. 128 Figure 11.25: Australia Skin Microbiome Modulators Market, 2019-2030 ....................................... 129 Figure 11.26: India Skin Microbiome Modulators Market, 2019-2030 .............................................. 130 Figure 11.27: RoAPAC Skin Microbiome Modulators Market, 2019-2030 ....................................... 131 Figure 11.28: Latin America Skin Microbiome Modulators Market, 2019-2030 ............................... 132 Figure 11.29: Latin America: Market Dynamics ................................................................................ 133 Figure 11.30: Latin America Skin Microbiome Modulators Market (by Country), 2019-2030 ......... 133 All rights reserved at BIS Research 13

14. Global Skin Microbiome Modulators Market Figure 11.31: Brazil Skin Microbiome Modulators Market, 2019-2030 ............................................ 134 Figure 11.32: Mexico Skin Microbiome Modulators Market, 2019-2030 .......................................... 135 Figure 11.33: Rest-of-Latin America Skin Microbiome Modulators Market, 2019-2030 .................. 136 Figure 11.34: RoW Skin Microbiome Modulators Market, 2019-2030 ............................................. 137 Figure 12.1: Total Number of Companies Profiled ............................................................................ 138 Figure 12.2: AOBiome (Mother Dirt): Product Portfolio ..................................................................... 140 Figure 12.3: AOBiome: Pipeline Products (Drugs) ............................................................................ 140 Figure 12.4: AOBiome: SWOT Analysis ............................................................................................ 141 Figure 12.5: Azitra, Inc.: Pipeline Products ....................................................................................... 143 Figure 12.6: Azitra, Inc.: SWOT Analysis .......................................................................................... 144 Figure 12.7: Colgate-Palmolive Company (Tom’s of Maine): Product Offerings ............................. 146 Figure 12.8. Colgate-Palmolive Company: Overall Financials, 2017-2019 ..................................... 147 Figure 12.9: Colgate-Palmolive Company: Revenue (by Segment), 2017-2019 ............................. 148 Figure 12.10: Colgate-Palmolive Company.: SWOT Analysis ......................................................... 149 Figure 12.11: Evelo Biosciences, Inc.: Pipeline Products ................................................................. 151 Figure 12.12: Evelo Biosciences, Inc.: SWOT Analysis .................................................................... 152 Figure 12.13: GALLINÉE: Product Portfolio ...................................................................................... 154 Figure 12.14: GALLINEE.: SWOT Analysis ...................................................................................... 155 Figure 12.15: Glowbiotics, Inc.: Product Portfolio ............................................................................. 157 Figure 12.16: Glowbiotics, Inc.: SWOT Analysis ............................................................................... 158 Figure 12.17: Johnson and Jonson Services, Inc. (Aveeno): Product Portfolio ............................... 160 Figure 12.18: Johnson & Johnson Services, Inc. Company: Overall Financials, 2017-2019 ......... 161 Figure 12.19: Johnson & Johnson Services, Inc. Company: R&D Expenditure, 2017-2019 ......... 162 Figure 12.20: Johnson & Johnson Services, Inc.: SWOT Analysis .................................................. 163 Figure 12.21: L’Oréal S.A.: Product Portfolio .................................................................................... 165 Figure 12.22: L’Oréal S.A Company: Overall Financials, 2017-2019 .............................................. 165 Figure 12.23: L’Oreal S.A.: SWOT Analysis ...................................................................................... 166 Figure 12.24: MATRISYS BIOSCIENCE: Pipeline Products Portfolio ............................................. 168 Figure 12.25: MATRISYS BIOSCIENCE: SWOT Analysis .............................................................. 169 All rights reserved at BIS Research 14

15. Global Skin Microbiome Modulators Market Figure 12.26: Quorum Innovations: Pipeline Product Portfolio ......................................................... 171 Figure 12.27: Quorum Innovations: SWOT Analysis ........................................................................ 172 Figure 12.28: Revlon (Elizabeth Arden, Inc.): Product Portfolio ....................................................... 174 Figure 12.29: Revlon: Overall Financials, 2017-2019 ....................................................................... 174 Figure 12.30: Revlon: Revenue (by Segment), 2017-2019 .............................................................. 175 Figure 12.31: Revlon (Elizabeth Arden): Revenue (by Region), 2017-2019 .................................... 176 Figure 12.32: Revlon: R&D Expenditure, 2017-2019 ........................................................................ 177 Figure 12.33: Revlon: SWOT Analysis .............................................................................................. 178 Figure 12.34: Siolta Therapeutics: Product Offerings ....................................................................... 180 Figure 12.35: Siolta Therapeutics: SWOT Analysis .......................................................................... 181 Figure 12.36: The Estee Lauder Companies, Inc.: Overall Product Portfolio .................................. 183 Figure 12.37: The Estee Lauder Companies Inc.: SWOT Analysis ................................................. 184 Figure 12.38: TULA Life, INC: Product Portfolio ............................................................................... 186 Figure 12.39: TULA Life, INC: SWOT Analysis ................................................................................. 187 Figure 12.40: Unilever: Product Portfolio ........................................................................................... 189 Figure 12.41: Unilever: Overall Financials, 2017-2019 ..................................................................... 190 Figure 12.42: Unilever: Revenue (by Segment), 2017-2019 ............................................................ 191 Figure 12.43: Unilever: SWOT Analysis ............................................................................................ 192 Figure 12.44: Yakult Honsha Co., Ltd.: Product Portfolio ................................................................. 194 Figure 12.45: Yakult Honsha Co., Ltd: Overall Financials, 2017-2019 ............................................ 195 Figure 12.46: Yakult Honsha Co., Ltd: Revenue (by Segment), 2017-2019 ................................... 196 Figure 12.47: Yakult Honsha Co., Ltd.: SWOT Analysis .................................................................. 197 All rights reserved at BIS Research 15

16. Global Skin Microbiome Modulators Market BIS BIS Researc Research Offerings: h Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. Know More Know More Know More Know More All rights reserved at BIS Research 16

17. Global Skin Microbiome Modulators Market Disclaimer Disclaimer BIS Research provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon several estimates and assumptions that, while considered reasonable by BIS Research as of the date of such statements, and are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies. For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 All rights reserved at BIS Research 17

18. Global Skin Microbiome Modulators Market BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: info@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 All rights reserved at BIS Research 18